Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,71 USD | +6,85% | +2,13% | +4,03% |
Vakgebied
Aantal werknemers: 116
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medicines
100,0
%
| 19 | 100,0 % | 34 | 100,0 % | +77,63% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 19 | 100,0 % | 34 | 100,0 % | +77,63% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-05-17 | |
Douglas Cole
FOU | Founder | 63 | 01-10-15 |
Stephen DiPalma
DFI | Director of Finance/CFO | 66 | 16/01 |
Fanny Cavalié
COO | Chief Operating Officer | 46 | - |
Steven Bellon
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-06-16 |
Chief Tech/Sci/R&D Officer | 53 | 11-09-23 | |
Andrew Germain
LAW | General Counsel | - | 01-01-20 |
Saurabh Sewak
PRN | Corporate Officer/Principal | - | 01-01-22 |
Carlos Costa
HRO | Human Resources Officer | 51 | - |
Michael LaCascia
LAW | General Counsel | 59 | 12-11-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simba Gill
BRD | Director/Board Member | 60 | 01-07-17 |
Douglas Cole
FOU | Founder | 63 | 01-10-15 |
B. Parshall
BRD | Director/Board Member | 69 | 16-08-22 |
Ian Smith
BRD | Director/Board Member | 58 | 27-04-21 |
Adam Koppel
BRD | Director/Board Member | 54 | 01-07-17 |
Thomas Lynch
BRD | Director/Board Member | 63 | 27-10-22 |
Director/Board Member | 69 | 01-04-17 | |
Scott Biller
BRD | Director/Board Member | 68 | 09-01-20 |
Chief Executive Officer | 49 | 01-05-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 42 565 904 | 31 609 530 ( 74,26 %) | 0 | 74,26 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,03% | 286 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |
- Beurs
- Aandelen
- Aandeel Foghorn Therapeutics Inc. - Nasdaq
- Onderneming Foghorn Therapeutics Inc.